Showing results (211-220 of 2,733) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|October 22, 2009
VKORC1 haplotypes in five East-Asian populations and IndiansMing Ta Michael Lee, Chien-Hsiun Chen, Hui-Ping Chuang, et al.
Pharmacogenomics|October 22, 2009
Genetic factors influencing cytarabine therapyJatinder K Lamba
Pharmacogenomics|June 9, 2017
Availability of CYP2D6 genotyping results in general practitioner and community pharmacy medical recordsMirjam Simoons, Hans Mulder, Robert A Schoevers, et al.
Pharmacogenomics|June 23, 2017
MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapyMatthew Goblirsch, Georg Richtig, Ondrej Slaby, et al.
Pharmacogenomics|June 23, 2017
Pathway analysis to identify genetic variants associated with efficacy of adalimumab in rheumatoid arthritisFrank Eektimmerman, Jesse J Swen, Stefan Böhringer, et al.
Pharmacogenomics|November 22, 2005
Translating RNA interference into therapies for human diseaseNagesh Mahanthappa
Pharmacogenomics|February 9, 2010
Errors and reproducibility of DNA array-based detection of allelic variants in ADME genes: PHARMAchipElisabet Cuyàs, Estibaliz Olano-Martín, Olha Khymenets, et al.
Pharmacogenomics|June 13, 2017
The impact of clinical and genetic factors on ticagrelor and clopidogrel antiplatelet therapyVacis Tatarunas, Nora Kupstyte, Remigijus Zaliunas, et al.
Pharmacogenomics|May 9, 2017
Should a routine genotyping of CYP2D6 and CYP2C19 genetic polymorphisms be recommended to predict venlafaxine efficacy in depressed patients treated in psychiatric settings?Adela Taranu, Romain Colle, Florence Gressier, et al.
Pharmacogenomics|April 10, 2018
A genetic polymorphism in the CYP1B1 gene in patients with squamous cell carcinoma of the esophagus: an Iranian Mashhad cohort study recruited over 10 yearsAzam Rastgar Moghadam, Mehrane Mehramiz, Malihe Entezari, et al.
Pageof 274